We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$6.69B
AUM Growth
-$75.7M
Cap. Flow
-$285M
Cap. Flow %
-4.26%
Top 10 Hldgs %
37.76%
Holding
142
New
36
Increased
36
Reduced
23
Closed
20

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$255M
2
META icon
Meta Platforms (Facebook)
META
+$149M
3
TWLO icon
Twilio
TWLO
+$109M
4
CPRT icon
Copart
CPRT
+$103M
5
AAPL icon
Apple
AAPL
+$94.3M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$214M
2
DG icon
Dollar General
DG
+$212M
3
DIS icon
Walt Disney
DIS
+$212M
4
FIVE icon
Five Below
FIVE
+$147M
5
NKE icon
Nike
NKE
+$143M

Sector Composition

Rank Sector Weight
1 Healthcare 23.95%
2 Technology 23.37%
3 Consumer Discretionary 18.23%
4 Industrials 16.77%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S icon
51
SentinelOne
S
$7.12B
$29.8M 0.45%
+701,000
New +$29.8M
KALV
52
DELISTED
KalVista Pharmaceuticals
KALV
$28.5M 0.43%
1,191,101
+231,209
+24% +$6.05M
SOFI icon
53
PUT
SoFi Technologies
SOFI
$23.4B
$27.6M 0.41%
1,440,000
-310,000
-18% -$5.75M
MREO
54
Mereo BioPharma
MREO
$48.8M
$27.4M 0.41%
8,649,300
+2,283,800
+36% +$7.66M
BGRY
55
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$24.9M 0.37%
2,500,708
+708
+0% +$7.08K
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$24M 0.36%
+148,872
New +$23.9M
DCPH
57
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$23.9M 0.36%
652,635
+315,827
+94% +$12.2M
HRTX icon
58
Heron Therapeutics
HRTX
$94.1M
$23.1M 0.35%
1,490,440
+984,403
+195% +$15.7M
AMAM
59
DELISTED
Ambrx Biopharma Inc
AMAM
$22.9M 0.34%
+1,169,529
New +$19.9M
SLDB icon
60
Solid Biosciences
SLDB
$857M
$21.9M 0.33%
398,280
– –
PNT
61
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$21M 0.31%
2,045,600
+969,600
+90% +$9.86M
AGC
62
DELISTED
Altimeter Growth Corp
AGC
$20.5M 0.31%
+1,753,264
New +$21.5M
FTCV
63
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
$20.3M 0.3%
+1,661,845
New +$19.2M
FBRX icon
64
Forte Biosciences
FBRX
$1.57B
$17.4M 0.26%
20,678
-3,322
-14% -$2.99M
FULC icon
65
Fulcrum Therapeutics
FULC
$288M
$17.1M 0.26%
1,627,444
+101,559
+7% +$1.03M
RXDX
66
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$15.4M 0.23%
625,625
+47,091
+8% +$1.05M
SIOX
67
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$15M 0.22%
5,489,000
– –
BOLT icon
68
Bolt Biotherapeutics
BOLT
$7.47M
$14.8M 0.22%
47,704
+26,686
+127% +$10.8M
SYRE icon
69
Spyre Therapeutics
SYRE
$9.11B
$14.6M 0.22%
83,764
+29,081
+53% +$5.28M
MQ icon
70
Marqeta
MQ
$1.74B
$14.1M 0.21%
+125,975
New +$15M
IRON icon
71
Disc Medicine
IRON
$2.98B
$13.8M 0.21%
71,167
+27,422
+63% +$9.02M
TERN
72
DELISTED
Terns Pharmaceuticals
TERN
$13.8M 0.21%
1,125,136
– –
KDNY
73
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$13.7M 0.2%
968,023
+418,408
+76% +$6.69M
OWL icon
74
Blue Owl Capital
OWL
$7.74B
$12.9M 0.19%
+1,000,000
New +$11.3M
INSM icon
75
Insmed
INSM
$28.8B
$12.6M 0.19%
+441,065
New +$13.1M
1 2
3
4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return

Suvretta Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Suvretta Capital Management held 142 positions worth $6.69B, down 1.1% from $6.76B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Suvretta Capital Management withdrew a net $285M in Q2 2021, closing 20 positions and reducing 23 holdings. Its most notable exit was McDonald's, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Suvretta Capital Management opened a new position in Alphabet (Google) Class C worth $269M.

  • Suvretta Capital Management's largest Q2 2021 buy was Alphabet (Google) Class C: 2,143,380 shares worth $269M.
  • Suvretta Capital Management added most to Amazon in Q2 2021, an estimated $88.8M increase.
  • Suvretta Capital Management's biggest Q2 2021 reduction was Five Below, cutting an estimated $147M.
  • Suvretta Capital Management fully exited McDonald's in Q2 2021, selling an estimated $214M.
  • Suvretta Capital Management's ten largest holdings make up 38% of its $6.69B portfolio in Q2 2021.
  • Suvretta Capital Management opened 36 new positions and closed 20 in Q2 2021.
  • Suvretta Capital Management's portfolio value fell 1.1% quarter-over-quarter to $6.69B.

Based on Suvretta Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.